Tuesday, October 1, 2024
HomeIndustries

Industries

Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes,...

Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease

Severe heart failure is the most life-threatening medical condition in all age groups across the globe. Implantable heart pumps, known as Ventricular Assist Devices...

Bielcor Announces New Lineup of N95 Masks As Omicron Surges

As individuals and employers scramble to find N95 masks for sale, Bielcor has stepped up with free two-day shipping, increased production, and new NIOSH-certified...

Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care

Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced a multi-year partnership with Illumina, Inc. (NASDAQ: ILMN), to...

Vestibular First adds enhanced infection control to low-cost vertigo diagnostic tool

Vestibular First LLC announced it has added a new infection control measure to its FDA-cleared, low-cost tool for diagnosing dizziness, imbalance and vertigo, which...
0FansLike
0FollowersFollow
spot_img

Hot Topics